LCE 150
Generic Name: carbidopa/entacapone/levodopa
Pill imprint LCE 150 has been identified as Stalevo 150 37.5 mg / 200 mg / 150 mg.
Stalevo 150 is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy.
Stalevo 150 37.5 mg / 200 mg / 150 mg is not subject to the Controlled Substances Act.
See also related documents.
Stalevo 150 Images
- Generic Name:
- carbidopa/entacapone/levodopa
- Imprint:
-
LCE 150
- Strength:
- 37.5 mg / 200 mg / 150 mg
- Color:
- Brown
- Size:
- 15.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- corn starch
croscarmellose sodium
glycerin
hypromelloses
magnesium stearate
mannitol
polysorbate 80
povidone
sucrose
ferric oxide red
titanium dioxide
ferric oxide yellow
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Novartis Pharmaceuticals
- National Drug Code (NDC):
- 00078-0409
More Stalevo 150 resources
- Stalevo 150 (Cerner Multum)
- Stalevo 150 (Micromedex) - Includes Dosage Information


